home / stock / vxrt / vxrt news


VXRT News and Press, Vaxart Inc. From 08/09/21

Stock Information

Company Name: Vaxart Inc.
Stock Symbol: VXRT
Market: NASDAQ
Website: vaxart.com

Menu

VXRT VXRT Quote VXRT Short VXRT News VXRT Articles VXRT Message Board
Get VXRT Alerts

News, Short Squeeze, Breakout and More Instantly...

VXRT - Why Shares of Vaxart Are Soaring Today

Shares of clinical-stage vaccine developer Vaxart (NASDAQ: VXRT) are up again today, gaining 12.34% to $9.83 apiece as of 2:30 p.m. EDT. The stock is up 21% over the past five trading days due to greater capital inflows after the company released encouraging second-quarter earnings ...

VXRT - 4 Penny Stocks On Robinhood To Watch This Week

Are These Robinhood Penny Stocks On Your Watch List This Week? Thanks to former penny stocks like AMC Entertainment ( NYSE: AMC ) and GameStop ( NYSE: GME ), traders are becoming more familiar with the potential of cheap stocks. Not only that, but the short squeeze and “g...

VXRT - Wall Street Breakfast (Podcast)

You can read the full article here. For further details see: Wall Street Breakfast (Podcast)

VXRT - Wall Street Breakfast: Eyeing Payrolls Progress

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Eyeing payrolls progressThe Federal Reserve wants to see “substantial progress” in the economy before it makes any move towards removing acco...

VXRT - Vaxart EPS beats by $0.01, beats on revenue

Vaxart (NASDAQ:VXRT): Q2 GAAP EPS of -$0.13 beats by $0.01. Revenue of $112000 vs. last year's $0.52M. Research and development expenses were $10.7 million for the second quarter of 2021 compared to $5.1 million for the second quarter of 2020. Vaxart ended the quarter...

VXRT - Vaxart Provides Business Update and Reports Second Quarter 2021 Financial Results

Vaxart Provides Business Update and Reports Second Quarter 2021 Financial Results Company makes advances with its disruptive oral vaccine portfolio Cash, cash equivalents, and marketable securities of $198.9 million as of June 30, 2021 PR Newswire SOUTH SAN FRA...

VXRT - Notable earnings before Thursday's open

AAWW,ABMD,ACIW,ADNT,AES,AHCO,AMRN,AMRS,APTV,ARW,ATH,BBIO,BCE,BDX,BEP,BERY,BIP,BKI,BLDR,BLL,BV,CAH,CARS,CCOI,CHH,CI,CNP,COMM,CQP,DDOG,DIN,DLX,DUK,ECOM,ECVT,EPAM,EPC,EVRG,FOCS,FOUR,FVRR,GCP,GIL,GOGO,GOLF,GRA,GTN,HBI,HII,HIMX,HL,IBP,IDCC,INSM,IRM,IRWD,ITRI,K,LNG,LXP,MMS,MRNA,MUR,NFE,NICE,NJR,NOM...

VXRT - The Bull Thesis for VXRT Stock is Questionable at Best

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors should simply avoid Vaxart (NASDAQ: VXRT ) stock at this time. Although VXRT stock has an interesting business model, there is arguably not much behind it. I’ll get to that in a moment, but Iȁ...

VXRT - California and NYC Order Mandatory COVID-19 Testing Among Municipal Workers

New York, NY – August 03, 2021 – New COVID-19 cases continue to surge throughout the United States, causing municipal governments to spring into action to combat the rising number of the highly infectious Delta variant cases. On Monday, California and New York City announced...

VXRT - Why Vaxart Stock Surged Today

Shares of Vaxart (Nasdaq: VXRT) rose on Monday after the biotech said the U.S. Food and Drug Administration (FDA) had cleared its Investigational New Drug (IND) application for its oral coronavirus vaccine. As of 2:20 p.m. EDT, Vaxart's stock price was up more than 12%. Vaxart's...

Previous 10 Next 10